GMP Biologics Market Projected to Reach USD 193.9 Billion by 2032, Driven by Rising Biopharmaceutical Demand and Expanding Biologics Pipeline Good Manufacturing Practice (GMP) Biologics Market Share is experiencing significant growth, propelled by increasing demand for biopharmaceuticals and an expanding pipeline of biologic drugs. According to a report by Market Research Future, the...